secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keenova Therapeutics plc (—)
CIK:        0001567892
Form:       8-K
Filed at:   2026-06-15T12:00:39+00:00
Accession:  0001104659-26-073787
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keenova Therapeutics to sell Percocet and Endocet businesses to Par Health for up to $250M
--------------------------------------------------------------------------------

- Upfront purchase price $25M; quarterly earnout payments over 5 years based on gross profit of the Business.
- Transaction expected to close in Q3 2026, subject to HSR clearance and other customary closing conditions.
- After closing, Keenova will no longer market, manufacture, or distribute opioid products.
- Consideration total up to ~$250M; deal includes Percocet and Endocet businesses sold to Par Health, Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567892/000110465926073787/0001104659-26-073787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567892/000110465926073787/tm2617927d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-073787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer